These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16511591)

  • 1. PPAR delta: a dagger in the heart of the metabolic syndrome.
    Barish GD; Narkar VA; Evans RM
    J Clin Invest; 2006 Mar; 116(3):590-7. PubMed ID: 16511591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.
    Coll T; Rodrïguez-Calvo R; Barroso E; Serrano L; Eyre E; Palomer X; Vázquez-Carrera M
    Curr Mol Pharmacol; 2009 Jan; 2(1):46-55. PubMed ID: 20021445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL; Lin JJ; Goldfine ID
    Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR delta agonists and metabolic diseases.
    Kang K; Hatano B; Lee CH
    Curr Atheroscler Rep; 2007 Jan; 9(1):72-7. PubMed ID: 17169250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease and PPARdelta: targeting the risk factors.
    Muscat GE; Dressel U
    Curr Opin Investig Drugs; 2005 Sep; 6(9):887-94. PubMed ID: 16187688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.
    Luquet S; Gaudel C; Holst D; Lopez-Soriano J; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochim Biophys Acta; 2005 May; 1740(2):313-7. PubMed ID: 15949697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome.
    Takahashi S; Tanaka T; Kodama T; Sakai J
    Pharmacol Res; 2006 Jun; 53(6):501-7. PubMed ID: 16713711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.
    Benetti E; Patel NS; Collino M
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):273-84. PubMed ID: 21696362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
    Grimaldi PA
    Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta.
    Ehrenborg E; Krook A
    Pharmacol Rev; 2009 Sep; 61(3):373-93. PubMed ID: 19805479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR) delta-selective ligands.
    Miyachi H
    Curr Med Chem; 2007; 14(22):2335-43. PubMed ID: 17896982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome.
    Grewal AS; Beniwal M; Pandita D; Sekhon BS; Lather V
    Med Chem; 2016; 12(1):3-21. PubMed ID: 26004782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARδ) in mice leads to increased susceptibility to diet-induced obesity.
    Kocalis HE; Turney MK; Printz RL; Laryea GN; Muglia LJ; Davies SS; Stanwood GD; McGuinness OP; Niswender KD
    PLoS One; 2012; 7(8):e42981. PubMed ID: 22916190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus.
    Jay MA; Ren J
    Curr Diabetes Rev; 2007 Feb; 3(1):33-9. PubMed ID: 18220654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic target for metabolic syndrome: PPARdelta.
    Takahashi S; Tanaka T; Sakai J
    Endocr J; 2007 Jun; 54(3):347-57. PubMed ID: 17409576
    [No Abstract]   [Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue.
    Roberts LD; Murray AJ; Menassa D; Ashmore T; Nicholls AW; Griffin JL
    Genome Biol; 2011 Aug; 12(8):R75. PubMed ID: 21843327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR delta: an uncompletely known nuclear receptor.
    Fredenrich A; Grimaldi PA
    Diabetes Metab; 2005 Feb; 31(1):23-7. PubMed ID: 15803109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.